AzTrials
AzTrials

InsomniaNCT04457674

Targeting Sleep Homeostasis to Improve Alcohol Use Disorder Treatment Outcomes (M-STAR Study)

A study testing Cognitive Behavioral Therapy for insomnia (CBTi) and Sleep Hygiene Education (SHE) in people with Insomnia and Alcohol Use Disorder, run by University of Michigan at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Insomnia is common in people who are in treatment for alcohol use disorder. It can impact both sleep quality and daytime functioning, as well as make it harder to treat the underlying alcohol use disorder. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Insomnia, Alcohol Use Disorder
What is being tested?
Cognitive Behavioral Therapy for insomnia (CBTi) and Sleep Hygiene Education (SHE)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
134 participants
Where
1 siteUnited States
Study dates
12 Nov 2020to 31 Mar 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Meet probable Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 criteria for Alcohol Use Disorder with ≤12 months of abstinence
  • Planned enrollment into an abstinence-based treatment program
  • Meet probable DSM-5 criteria for chronic insomnia
  • Access to a video chat-capable device and reliable Wi-Fi network

Who cannot join

  • Diagnosis of, or high suspicion for, sleep disorders other than insomnia
  • Meet probable DSM-5 criteria for bipolar disorder, psychotic disorder, or post-traumatic stress disorder (PTSD)
  • Terminal or progressive physical illness (e.g., cancer), neurological degenerative disease (e.g., dementia), or presence of an unstable medical condition that is the specific cause of insomnia
  • Self-reported pregnancy or intention to become pregnant during the study

Trial locations and contacts

1 site in 1 country.

United States1 site
  • The University of Michigan

    Ann Arbor, Michigan, 48109

Other trials in United States

About this study

Official title: Targeting Sleep Homeostasis to Improve Alcohol Use Disorder Treatment Outcomes

Insomnia is common in people who are in treatment for alcohol use disorder. It can impact both sleep quality and daytime functioning, as well as make it harder to treat the underlying alcohol use disorder. This study is looking at two types of therapy to help manage insomnia specifically for people also in treatment for alcohol use disorder.

Being tested
Cognitive Behavioral Therapy for insomnia (CBTi), Sleep Hygiene Education (SHE)
Keywords
Cognitive Behavioral Therapy, Sleep Hygiene
Medical subject headings
Sleep Initiation and Maintenance Disorders, Alcoholism, Sleep Hygiene

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cognitive Behavioral Therapy for insomnia (CBTi)Behavioural

    CBTi consists of six weekly sessions of individual therapy with a trained therapist, delivered via telemedicine.

  • Sleep Hygiene Education (SHE)Behavioural

    SHE participants receive six weekly sessions of individual therapy with a trained therapist, delivered via telemedicine.

Study groups in NCT04457674
Study groupRoleWhat they receive
Cognitive Behavioral Therapy for insomnia (CBTi)OtherCBTi is a non-medication therapy that includes cognitive and behavioral treatment components.
Receives: Behavioral: Cognitive Behavioral Therapy for insomnia (CBTi)
Sleep Hygiene Education (SHE)OtherSHE is a non-medication therapy that focuses on identifying and changing several behavioral and environmental factors that can interfere with sleep.
Receives: Behavioral: Sleep Hygiene Education (SHE)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Score from the insomnia severity index (ISI)

    The ISI is a 7-item self-report assessment of the nature, severity and impact of insomnia. Scores range from 0-28 with higher scores suggesting more clinically significant insomnia.

    Measured: Immediately post treatment

  2. Percent days abstinent from alcohol as documented in the timeline follow-back (TLFB)

    The Alcohol TLFB is an interviewer-based drinking assessment method to estimate drinking behaviors, including both frequency and quantity of consumption.

    Measured: Immediately post treatment

Secondary outcomes (1)
  1. Score from Multidimensional Fatigue Inventory (MFI), General Fatigue sub-scale

    The MFI is a 20-item assessment that provides an overall fatigue score (20-100) in addition to 5 separate dimensions of fatigue: general fatigue, physical fatigue, reduced motivation, reduced activity, and mental fatigue. Sub-scale scores range from 4-20 with higher scores indicating higher levels of fatigue.

    Measured: Immediately post treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Jul 2020
  2. Study start12 Nov 2020
  3. Primary completion31 Mar 2026
  4. Study completion31 Mar 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
134 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04457674
Sponsor's protocol ID
HUM00173631
Other IDs
R01AA028158
Status last verified
May 2026
First submitted
29 Jun 2020
Last updated
13 May 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-identified data will be shared through the National Institute of Mental Health (NIMH) Data Archive. Only information relevant to the research project will be shared, which may include demographic information such as gender and age, responses to surveys and results found from the research project. Participants identifying data will not be shared in any way and information related to participants will be given a different random identifier known as a Global Unique Identifier or GUID. This number will not coincide with any identifier for data stored on University of Michigan study databases.

Questions about this trial

What is this clinical trial studying?

A study testing Cognitive Behavioral Therapy for insomnia (CBTi) and Sleep Hygiene Education (SHE) in people with Insomnia and Alcohol Use Disorder, run by University of Michigan at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Score from the insomnia severity index (ISI) (time frame: Immediately post treatment). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in